Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.COMM(CGON) | 3,670,206 | 3,670,206 | 0 | $115.87M | $138.48M | 11.73% | +$22.61M |
| Dyne Therapeutics, Inc.COMM(DYN) | 2,650,150 | 2,650,150 | 0 | $93.52M | $95.19M | 8.07% | +$1.67M |
| Cogent Biosciences, Inc.COMM(COGT) | 6,964,375 | 6,964,375 | 0 | $58.71M | $75.22M | 6.37% | +$16.51M |
| ABIVAX Société AnonymeADRS(ABVX) | 6,056,596 | 6,056,596 | 0 | $80.07M | $69.77M | 5.91% | -$10.30M |
| Edgewise Therapeutics, Inc.COMM(EWTX) | 2,272,728 | 2,112,984 | -159,744 | $40.93M | $56.40M | 4.78% | +$15.46M |
| Silence Therapeutics plcADRS(SLN) | 3,295,350 | 3,033,560 | -261,790 | $62.61M | $55.15M | 4.67% | -$7.46M |
| Savara Inc.COMM(SVRA) | 12,362,205 | 12,362,205 | 0 | $49.82M | $52.42M | 4.44% | +$2.60M |
| Keros Therapeutics, Inc.COMM(KROS) | 879,344 | 879,344 | 0 | $40.19M | $51.06M | 4.33% | +$10.88M |
| Xencor, Inc.COMM(XNCR) | 0 | 2,427,138 | +2,427,138 | $0 | $48.81M | 4.14% | +$48.81M |
| Tyra Biosciences, Inc.COMM(TYRA) | 1,989,103 | 1,989,103 | 0 | $31.81M | $46.76M | 3.96% | +$14.96M |
| Structure Therapeutics IncADRS | 694,547 | 1,063,000 | +368,453 | $27.27M | $46.66M | 3.95% | +$19.38M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 5,319,148 | 5,319,148 | 0 | $36.38M | $46.28M | 3.92% | +$9.89M |
| Centessa Pharmaceuticals PlcCOMM | 2,890,816 | 2,890,816 | 0 | $26.10M | $46.22M | 3.92% | +$20.12M |
| Tourmaline Bio IncCOMM | 1,477,593 | 1,477,593 | 0 | $19.00M | $37.99M | 3.22% | +$18.99M |
| Third Harmonic Bio IncCOMM | 0 | 2,415,000 | +2,415,000 | $0 | $32.72M | 2.77% | +$32.72M |
| Astria Therapeutics, Inc.COMM | 2,761,861 | 2,761,861 | 0 | $25.13M | $30.41M | 2.58% | +$5.28M |
| Mineralys Therapeutics, Inc.COMM(MLYS) | 3,185,185 | 2,470,265 | -714,920 | $37.27M | $29.91M | 2.53% | -$7.35M |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 1,423,642 | 0 | $29.31M | $27.82M | 2.36% | -$1.49M |
| Soleno Therapeutivs, Inc.COMM | 0 | 550,000 | +550,000 | $0 | $27.77M | 2.35% | +$27.77M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 3,858,000 | 0 | $23.30M | $24.31M | 2.06% | +$1.00M |
| Disc Medicine, Inc.COMM(IRON) | 486,957 | 486,957 | 0 | $21.95M | $23.93M | 2.03% | +$1.98M |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 0 | 5,250,000 | +5,250,000 | $0 | $18.74M | 1.59% | +$18.74M |
| MBX Biosciences, Inc.COMM(MBX) | 0 | 650,000 | +650,000 | $0 | $16.89M | 1.43% | +$16.89M |
| Amylyx Pharmaceuticals, Inc.COMM(AMLX) | 0 | 4,643,812 | +4,643,812 | $0 | $15.05M | 1.27% | +$15.05M |
| Adverum Biotechnologies, Inc.COMM | 0 | 2,008,339 | +2,008,339 | $0 | $14.10M | 1.19% | +$14.10M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $8.34M | $9.35M | 0.79% | +$1.01M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 0 | 2,676,580 | +2,676,580 | $0 | $8.06M | 0.68% | +$8.06M |
| Tarsus Pharmaceuticals, Inc.COMM(TARS) | 556,317 | 231,820 | -324,497 | $15.12M | $7.62M | 0.65% | -$7.50M |
| EyePoint, Inc.COMM(EYPT) | 922,335 | 922,335 | 0 | $8.02M | $7.37M | 0.62% | -$654.9K |
| Nektar TherapeuticsCOMM(NKTR) | 4,000,000 | 4,000,000 | 0 | $4.96M | $5.20M | 0.44% | +$240.0K |
| Aerovate Therapeutics IncCOMM | 2,240,809 | 2,240,809 | 0 | $3.72M | $4.68M | 0.40% | +$963.5K |
| Avalo Therapeutics, Inc.COMM(AVTX) | 0 | 483,000 | +483,000 | $0 | $4.59M | 0.39% | +$4.59M |
| Kodiak Sciences Inc.COMM(KOD) | 899,999 | 1,008,158 | +108,159 | $2.11M | $2.63M | 0.22% | +$516.3K |
| AN2 Therapeutics, Inc.COMM | 1,555,118 | 1,555,118 | 0 | $3.34M | $1.66M | 0.14% | -$1.68M |
| Ventyx Biosciences, IncCOMM | 316,195 | 316,195 | 0 | $730.4K | $689.3K | 0.06% | -$41.1K |
| Cabaletta Bio, Inc.COMM(CABA) | 86,795 | 86,795 | 0 | $649.2K | $409.7K | 0.03% | -$239.6K |
| Adverum Biotechnologies, Inc.COMM | 2,008,340 | 0 | -2,008,340 | $13.78M | $0 | — | -$13.78M |
| C4 Therapeutics, Inc.COMM(CCCC) | 1,276,574 | 0 | -1,276,574 | $5.90M | $0 | — | -$5.90M |
| Madrigal Pharmaceuticals, Inc.COMM(MDGL) | 149,283 | 0 | -149,283 | $41.82M | $0 | — | -$41.82M |
| Soleno Therapeutivs, Inc.COMM | 550,000 | 0 | -550,000 | $22.44M | $0 | — | -$22.44M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 0 | -2,676,580 | $9.31M | $0 | — | -$9.31M |